People · Operator
Named in public records as an officer, director or promoter · active 2014–2015 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| X2 Biosystems, Inc. | — | Other Technology | Series A | $22.2M | $9.7M | 2014 |
| Novuson Surgical, Inc. | — | Biotechnology | Seed | $2.9M | $105.8M | 2015 |
Christoph E Mack at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christoph E Mack on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert G Rosen | 1 | 2 |
| Christoph Mack | 1 | 1 |
| Jim Mora | 1 | 1 |
| Francesco P Curra | 1 | 1 |
| Stuart B Mitchell | 1 | 1 |
| John G. Ralston | 1 | 1 |
| Chris G. Siege | 1 | 1 |
| Richard E. Able | 1 | 1 |
| Peter Noone | 1 | 1 |
| Richard Able | 1 | 1 |
| John Ralston | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.